Insights

Global Manufacturing Network Recipharm operates development and manufacturing facilities across Europe, India, and the US, providing a broad geographic footprint that enables tailored and localized service delivery, making it an attractive partner for clients seeking global reach and regional expertise.

Technology Innovation The company's recent focus on developing AI-enabled manufacturing technologies and gene editing solutions indicates a commitment to cutting-edge innovation, presenting opportunities for collaborations in advanced biopharmaceutical manufacturing and biologics development.

Strategic Partnerships Recipharm's collaborations with NeuroSense Therapeutics, Edmolin, and McCarty Technologies demonstrate an openness to strategic alliances in complex therapeutic areas like ALS and gene editing, which could open avenues for joint projects in emerging and high-growth segments.

Financial and Investment Growth With a revenue range of 100M to 250M USD and recent significant grants from the Gates Foundation, Recipharm shows financial stability and growth potential, making it an appealing partner for co-investment and long-term development projects in innovative pharmaceuticals.

Market Expansion & Diversification Recent sales of facilities and expansion into new markets and therapeutic areas suggest a proactive approach to market diversification and capacity growth, creating opportunities to offer complementary services and solutions aligned with their evolving portfolio.

Recipharm Tech Stack

Recipharm uses 8 technology products and services including Salesforce Lightning, Microsoft Intune, ISO/IEC 27001, and more. Explore Recipharm's tech stack below.

  • Salesforce Lightning
    Application Development & Management
  • Microsoft Intune
    Enterprise Mobility Management
  • ISO/IEC 27001
    Governance, Risk And Compliance
  • Microsoft Entra ID
    Identity And Access Management
  • Slick
    Javascript Libraries
  • Cisco
    Network Hardware
  • Brainshark
    Sales Enablement
  • VMware vSphere
    Virtualisation Software

Media & News

Recipharm's Email Address Formats

Recipharm uses at least 1 format(s):
Recipharm Email FormatsExamplePercentage
First.Last@recipharm.comJohn.Doe@recipharm.com
96%
LastFir@recipharm.comDoeJoh@recipharm.com
1%
First.Middle@recipharm.comJohn.Michael@recipharm.com
2%
Last.First@recipharm.comDoe.John@recipharm.com
1%

Frequently Asked Questions

Where is Recipharm's headquarters located?

Minus sign iconPlus sign icon
Recipharm's main headquarters is located at 10 Vasagatan Stockholm, Stockholm 111 20 Sweden. The company has employees across 5 continents, including EuropeAsiaNorth America.

What is Recipharm's official website and social media links?

Minus sign iconPlus sign icon
Recipharm's official website is recipharm.com and has social profiles on LinkedInCrunchbase.

What is Recipharm's NAICS code?

Minus sign iconPlus sign icon
Recipharm's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Recipharm have currently?

Minus sign iconPlus sign icon
As of May 2026, Recipharm has approximately 3.1K employees across 5 continents, including EuropeAsiaNorth America. Key team members include Cso: K. L.Chief Financial Officer: R. J. S.Chief Operating Officer: L. B.. Explore Recipharm's employee directory with LeadIQ.

What industry does Recipharm belong to?

Minus sign iconPlus sign icon
Recipharm operates in the Pharmaceutical Manufacturing industry.

What technology does Recipharm use?

Minus sign iconPlus sign icon
Recipharm's tech stack includes Salesforce LightningMicrosoft IntuneISO/IEC 27001Microsoft Entra IDSlickCiscoBrainsharkVMware vSphere.

What is Recipharm's email format?

Minus sign iconPlus sign icon
Recipharm's email format typically follows the pattern of First.Last@recipharm.com. Find more Recipharm email formats with LeadIQ.

How much funding has Recipharm raised to date?

Minus sign iconPlus sign icon
As of May 2026, Recipharm has raised $32M in funding. The last funding round occurred on Jan 27, 2016 for $32M.

When was Recipharm founded?

Minus sign iconPlus sign icon
Recipharm was founded in 1995.

Recipharm

Pharmaceutical ManufacturingStockholm, Sweden1001-5000 Employees

Recipharm is a leading global CDMO dedicated to meeting your evolving needs through operational excellence, scientific know-how, and customer connectivity.
 
We operate development and manufacturing facilities in France, Germany, India, Italy, Portugal, Spain, Sweden, the UK and the US and are continuing to grow and expand our offering. 
 
Our worldwide reach paired with in-depth, localised market knowledge allows us to anticipate our customers’ needs and strengthen the support we provide to forge a healthier, more expansive and more fruitful future together.
 
With a workforce of 4,500 people, we are focused on supporting pharmaceutical companies with our full-service offering, taking products from early development through to commercial production. Since our inception in 1995, we have supported our customers throughout the entire product lifecycle, providing pharmaceutical expertise and managing complexity, time and time again to ensure their products are delivered with certainty.

Section iconCompany Overview

Headquarters
10 Vasagatan Stockholm, Stockholm 111 20 Sweden
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
1995
Employees
1001-5000

Section iconFunding & Financials

  • $32M

    Recipharm has raised a total of $32M of funding over 2 rounds. Their latest funding round was raised on Jan 27, 2016 in the amount of $32M.

  • $100M$250M

    Recipharm's revenue is estimated to be in the range of $100M$250M

Section iconFunding & Financials

  • $32M

    Recipharm has raised a total of $32M of funding over 2 rounds. Their latest funding round was raised on Jan 27, 2016 in the amount of $32M.

  • $100M$250M

    Recipharm's revenue is estimated to be in the range of $100M$250M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.